Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
PRILOZI
Volume 44 (2023): Issue 2 (July 2023)
Open Access
Biologic Therapy in Inflammatory Bowel Disease - Results from a Single Tertiary Care Center in North Macedonia
Gjorgi Deriban
Gjorgi Deriban
,
Dafina Nikolova
Dafina Nikolova
,
Fani Licoska
Fani Licoska
,
Emilija Trpcevska Nikolovska
Emilija Trpcevska Nikolovska
,
Vladimir Andreevski
Vladimir Andreevski
,
Kalina Stardelova
Kalina Stardelova
and
Vladimir Serafimoski
Vladimir Serafimoski
| Jul 15, 2023
PRILOZI
Volume 44 (2023): Issue 2 (July 2023)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jul 15, 2023
Page range:
41 - 46
DOI:
https://doi.org/10.2478/prilozi-2023-0023
Keywords
Inflammatory bowel disease
,
Crohn’s disease
,
Ulcerative colitis
,
Biological therapy
,
Infliximab
,
Adalimumab
© 2023 Gjorgi Deriban et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.